Kaisai Biotech releases a performance brief, reporting that in 2025 the company achieved operating revenue of 3.295 billion yuan, an increase of 11.41% year-over-year; total profit of 632 million yuan, up 15.23%; net profit attributable to shareholders of the listed company of 566 million yuan, up 15.70%; and net profit attributable to shareholders of the listed company excluding non-recurring gains and losses of 526 million yuan, an increase of 13.17%.
View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Kaisai Biotech: Net profit of 566 million yuan in 2025, a year-on-year increase of 15.70%
Kaisai Biotech releases a performance brief, reporting that in 2025 the company achieved operating revenue of 3.295 billion yuan, an increase of 11.41% year-over-year; total profit of 632 million yuan, up 15.23%; net profit attributable to shareholders of the listed company of 566 million yuan, up 15.70%; and net profit attributable to shareholders of the listed company excluding non-recurring gains and losses of 526 million yuan, an increase of 13.17%.